Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of REGN will decline by -2.97% over the next 2 Weeks and hit $582.13 by Wednesday, October 15, 2025. In that time frame, REGN's share price is expected to range between $565.19 and $597.99.
BearishAverageBullishREGN shares rose +0.01% in Thursday, October 2, 2025's trading session, rising from a previous close of $599.94 to move at $600.00. The stock demonstrated notable intraday movement (see REGN's key stats for a full breakdown), fluctuating between $596.60 and $605.41, a +1.48% trading range. While recent weeks have seen some volatility, REGN has managed to secure a +1.35% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.09M shares changing hands, 987.52K fewer than the previous session. This amounted to $656.85M in total market activity.
Will REGN Continue Its Downward Trend?
According to analyst ratings and projections for REGN, Regeneron Pharmaceuticals, Inc. shares are anticipated to decrease by -0.34%, potentially reaching $597.99 per share by October 15, 2025. Short-term technical indicators currently suggest a neutral sentiment for REGN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the REGN stock forecast, now is not the best time to buy REGN stock because its current trading price is +3.07% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on REGN covering social and institutional perspectives.
REGN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into REGN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.40% to 63.19%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 52.22%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.39%, maintains a neutral outlook for the long term. Insights into REGN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Regeneron Pharmaceuticals Short-Term Forecasts
REGN Forecast For Next 5 Days
Our algorithm anticipates Regeneron Pharmaceuticals (REGN) stock could hit $590.23 by Oct 09, 2025. This represents a -1.63% rise from today's price, following a +3.98% change over the past five days.
REGN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Regeneron Pharmaceuticals, Inc. (REGN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $598.93, which would mean a -0.18% decrease from the current price of $600.00. Projections for this period range from a high of $632.60 to a low of $570.94.
REGN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Regeneron Pharmaceuticals's price over the next three months point to a drop. REGN stock is expected to peak at $701.45 on Oct 13, 2025 before potentially dipping to $470.75 on Dec 15, 2025. On average, REGN is likely to trade around $562.72 in the coming 90 days.
Regeneron Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Regeneron Pharmaceuticals (REGN) is expected to trade between $470.75 and $701.45 throughout 2025. This would result in an average price of $562.92, potentially offering investors a -6.18% return from current levels.
Regeneron Pharmaceuticals, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, Regeneron Pharmaceuticals, Inc. (REGN) is positioned to show a strong performance in October 2025. The price is predicted to move between $510.76 and $701.45, settling at an average of $591.29. This could translate to a -1.45% loss.
November 2025
Based on current market signals, Regeneron Pharmaceuticals, Inc. is projected to trend november 2025. We forecast a trading range from $474.73 to $639.53, with a likely average price of $551.14. Investors could expect a potential return of -8.14%.
December 2025
Our predictive algorithms indicate Regeneron Pharmaceuticals, Inc. stock may see a shift in December 2025. The expected range spans $470.75–$627.34, with an average target of $546.02. This represents a cautious outlook and a possible loss of -9.00%.
January 2026
Analyzing established trends, Regeneron Pharmaceuticals, Inc. looks set to move in January 2026. Projections place the stock between $472.52 and $627.79, averaging around $549.84. This suggests a -8.36% loss from current levels.
February 2026
Market indicators suggest Regeneron Pharmaceuticals, Inc. could experience notable changes during February 2026. Prices could fluctuate within $470.14 to $638.13, with a midpoint forecast of $552.76. The stock might deliver a -7.87% loss.
March 2026
Forecasting for March 2026, models estimate that Regeneron Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $499.23 and $667.10, averaging $581.83. This signals a cautious trajectory with potential returns around -3.03%.
April 2026
According to our latest forecast models, Regeneron Pharmaceuticals, Inc. (REGN) is positioned to show a strong performance in April 2026. The price is predicted to move between $466.95 and $630.98, settling at an average of $544.74. This could translate to a -9.21% loss.
May 2026
Based on current market signals, Regeneron Pharmaceuticals, Inc. is projected to trend may 2026. We forecast a trading range from $465.48 to $616.59, with a likely average price of $538.06. Investors could expect a potential return of -10.32%.
June 2026
Our predictive algorithms indicate Regeneron Pharmaceuticals, Inc. stock may see a shift in June 2026. The expected range spans $472.15–$618.90, with an average target of $542.78. This represents a cautious outlook and a possible loss of -9.54%.
July 2026
Analyzing established trends, Regeneron Pharmaceuticals, Inc. looks set to move in July 2026. Projections place the stock between $464.13 and $637.79, averaging around $550.43. This suggests a -8.26% loss from current levels.
August 2026
Market indicators suggest Regeneron Pharmaceuticals, Inc. could experience notable changes during August 2026. Prices could fluctuate within $493.48 to $649.98, with a midpoint forecast of $572.48. The stock might deliver a -4.59% loss.
September 2026
Forecasting for September 2026, models estimate that Regeneron Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $458.93 and $608.50, averaging $536.15. This signals a cautious trajectory with potential returns around -10.64%.
October 2026
According to our latest forecast models, Regeneron Pharmaceuticals, Inc. (REGN) is positioned to show a strong performance in October 2026. The price is predicted to move between $476.21 and $600.91, settling at an average of $540.82. This could translate to a -9.86% loss.
REGN's history of dividends and stock splits also plays a role in long-term investor confidence.